23 results on '"Fellin, Giovanni"'
Search Results
2. Predicting Late Fecal Incontinence Risk After Radiation Therapy for Prostate Cancer: New Insights From External Independent Validation
3. Daily Sodium Butyrate Enema for the Prevention of Radiation Proctitis in Prostate Cancer Patients Undergoing Radical Radiation Therapy: Results of a Multicenter Randomized Placebo-Controlled Dose-Finding Phase 2 Study
4. Is It Time to Tailor the Prediction of Radio-Induced Toxicity in Prostate Cancer Patients? Building the First Set of Nomograms for Late Rectal Syndrome
5. FOURTEEN YEARS OF EXPERIENCE IN LOW DOSE RATE BRACHYTHERAPY FOR EARLY-STAGE PROSTATE CANCER IN ITALY: CHARACTERISTICS AND BIOCHEMICAL OUTCOMES IN A COHORT OF 2279 PATIENTS FROM NINE ITALIAN CENTRES: MP46-12
6. RECURRENT PROSTATE CANCER GENOMIC ALTERATIONS PREDICT RESPONSE TO BRACHYTHERAPY TREATMENT: MP24-13
7. TOWARDS THE MULTIDISCIPLINARY MANAGEMENT OF PROSTATE CANCER PATIENTS: THE PERSTEP PROJECT EXPERIENCE
8. Metamodeling of late rectal bleeding in patients undergoing radiotherapy for prostate cancer.
9. Predicting late fecal incontinence risk after RT for prostate cancer: External independent validation.
10. Low dose rate brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: practice and outcome analysis in a series of 2237 patients from 11 institutions
11. Assessment of clinical outcomes and prognostic factors in patients (pts) with non-small cell lung carcinoma (NSCLC) and brain metastases (BM): Results from a single institution.
12. Modeling severe late rectal bleeding: Results on a large pooled population of prostate cancer patients.
13. Impact of post-implant dosimetric parameters on the quality of life of patients treated with low-dose rate brachytherapy for localised prostate cancer: results of a single-institution study
14. Prognostic factors in muscle-infiltrating bladder cancer (MIBC) treated with an organ-sparing treatment with concurrent gemcitabine (GEM) and radiotherapy (XRT): Results of a patient-based cumulative analysis of seven phase I-II trials.
15. Concurrent gemcitabine (GEM) and radiotherapy (XRT) as organ-sparing treatment for muscle-infiltrating bladder cancer (MIBC): Preliminary results of a patient-based cumulative analysis of seven phase I-II trials.
16. Abstract 3952: Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment
17. MP46-12 FOURTEEN YEARS OF EXPERIENCE IN LOW DOSE RATE BRACHYTHERAPY FOR EARLY-STAGE PROSTATE CANCER IN ITALY: CHARACTERISTICS AND BIOCHEMICAL OUTCOMES IN A COHORT OF 2279 PATIENTS FROM NINE ITALIAN CENTRES
18. MP24-13 WITHDRAWN: RECURRENT PROSTATE CANCER GENOMIC ALTERATIONS PREDICT RESPONSE TO BRACHYTHERAPY TREATMENT
19. Recurrent Prostate Cancer Genomic Alterations Predict Response to Brachytherapy Treatment
20. Modeling fecal incontinence symptoms 6 years after high-dose radiation for prostate cancer: Clinical and dosimetric predictors.
21. La Radioterapia Intraoperatoria Nel Trattamento Integrato Del Carcinoma Pancreatico
22. Stage I Seminoma of the Testis: Long Term Results and Toxicity with Adjuvant Radiotherapy
23. MP24-13 RECURRENT PROSTATE CANCER GENOMIC ALTERATIONS PREDICT RESPONSE TO BRACHYTHERAPY TREATMENT.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.